Kynaston H - Search Results

1

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).

Lane JA, Donovan JL, Young GJ, Davis M, Walsh EI, Avery KNL, Blazeby JM, Mason MD, Martin RM, Peters TJ, Turner EL, Wade J, Bollina P, Catto JWF, Doherty A, Gillatt D, Gnanapragasam V, Hughes O, Kockelbergh R, Kynaston H, Oxley J, Paul A, Paez E, Rosario DJ, Rowe E, Staffurth J, Neal DE, Hamdy FC, Metcalfe C; Prostate Testing for Cancer and Treatment (ProtecT) Study Group. Lane JA, et al. Among authors: kynaston h. BJU Int. 2022 Sep;130(3):370-380. doi: 10.1111/bju.15739. Epub 2022 May 3. BJU Int. 2022. PMID: 35373443 Free PMC article. Clinical Trial.

2

Substitution cystoplasty for intractable interstitial cystitis.

Hughes OD, Kynaston HG, Jenkins BJ, Stephenson TP, Vaughton KC. Hughes OD, et al. Among authors: kynaston hg. Br J Urol. 1995 Aug;76(2):172-4. doi: 10.1111/j.1464-410x.1995.tb07668.x. Br J Urol. 1995. PMID: 7663907

3

Gangrenous cystitis in a paraplegic patient. Case report.

Hughes OD, Brough SJ, Kynaston HG, Jenkins BJ. Hughes OD, et al. Among authors: kynaston hg. Paraplegia. 1994 Sep;32(9):622-3. doi: 10.1038/sc.1994.98. Paraplegia. 1994. PMID: 7997342 No abstract available.

4

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

Shelley MD, Kynaston H, Court J, Wilt TJ, Coles B, Burgon K, Mason MD. Shelley MD, et al. Among authors: kynaston h. BJU Int. 2001 Aug;88(3):209-16. doi: 10.1046/j.1464-410x.2001.02306.x. BJU Int. 2001. PMID: 11488731 Review.

5

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer.

Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF, Davies JS. Smith JC, et al. Among authors: kynaston hg. J Clin Endocrinol Metab. 2001 Sep;86(9):4261-7. doi: 10.1210/jcem.86.9.7851. J Clin Endocrinol Metab. 2001. PMID: 11549659 Clinical Trial.

6

Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma.

Griffiths DF, Verghese A, Golash A, Kynaston HG, Matthews PN, Hart AJ, Court JB. Griffiths DF, et al. Among authors: kynaston hg. BJU Int. 2002 Jul;90(1):26-31. doi: 10.1046/j.1464-410x.2002.02661.x. BJU Int. 2002. PMID: 12081764

7

The prevalence and predictors of psychological distress in patients with early localized prostate cancer.

Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H. Bisson JI, et al. Among authors: kynaston h. BJU Int. 2002 Jul;90(1):56-61. doi: 10.1046/j.1464-410x.2002.02806.x. BJU Int. 2002. PMID: 12081771

8

Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma.

Thomas DH, Verghese A, Kynaston HG, Griffiths DF. Thomas DH, et al. Among authors: kynaston hg. Histopathology. 2003 Oct;43(4):374-80. doi: 10.1046/j.1365-2559.2003.01721.x. Histopathology. 2003. PMID: 14511256

9

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Shelley MD, et al. Among authors: kynaston h. BJU Int. 2004 Mar;93(4):485-90. doi: 10.1111/j.1464-410x.2003.04655.x. BJU Int. 2004. PMID: 15008714 Review.

10

Hepatocyte growth factor/scatter factor and prostate cancer: a review.

Hurle RA, Davies G, Parr C, Mason MD, Jenkins SA, Kynaston HG, Jiang WG. Hurle RA, et al. Among authors: kynaston hg. Histol Histopathol. 2005 Oct;20(4):1339-49. doi: 10.14670/HH-20.1339. Histol Histopathol. 2005. PMID: 16136515 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page